CONTROL OF CELL FUNCTION VIA SELECTIVE MRNA TRANSLATION

通过选择性 mRNA 翻译控制细胞功能

基本信息

  • 批准号:
    3301115
  • 负责人:
  • 金额:
    $ 28.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-07-01 至 1994-06-30
  • 项目状态:
    已结题

项目摘要

A complete understanding of the molecular mechanisms of disease will require elucidation of control mechanisms which define cell structure and function. The goals of this project are to define the molecular basis of selective messenger RNA translation and to characterize features of mRNA sequence and/or structure which signal formation of a specific messenger RNA protein complex. Stressed or virus-infected cells selectively translate a subset of the total mRNA pool, and nucleotides in the 5' untranslated leader sequence of the messenger RNAs facilitate differential expression. A plant viral messenger RNA, alfalfa mosaic virus RNA 4, will be exploited for these studies because it is expressed efficiently and selectively in extracts prepared from human cells infected with poliovirus wherein translocation of other messenger RNAs is abolished. Identification of the sequence and/or structural features of alfalfa mosaic virus RNA 4(AMV RNA 4) which sustain translational activity in diseased cells will increase understanding of how messenger RNAs are normally selected for translation and may suggest protocols for combating viral infection or for prevention of cell shut-down during stress conditions. Preliminary studies show that signals which permit selective translation. A combination of nucleotide deletion experiments and peptide complementation analyses will be used to characterize the molecular basis of selective AMV RNA 4 translation. Despite the implication that specific messenger RNA- protein interactions form the basis of important regulatory mechanisms, very few examples of specific mRNA-protein complexes have been described an studied in detail. Preliminary studies demonstrate that two unrelated proteins bind specifically to a 3'- terminal fragment of AMV RNA 4. Analysis of the specific binding of the AMV coat protein (CP) and of the mammalian double strand RNA-dependent protein kinase (dsI) to a 180 nucleotide fragment of RNA 4 offers an uncommon opportunity to examine mRNA protein interactions. Characterization of the AMV RNA 4-CP complex will be useful for understanding the molecular basis of viral cross- protection in plants; moreover, preliminary studies show that the plant viral RNA fragment is a potent activator of the mammalian dsI kinase. Mobility band shift electrophoresis and nitrocellulose filter retention studies will be used to characterize the specific interaction between alfalfa mosaic virus RNA 4 and CP/dsI. Nucleotide deletion analysis and site-directed mutagenesis will be used to probe both the RNA and the protein binding sites. The availability of large quantities of CP permits extension of the analysis to include physical studies. Direct clinical relevance may be found in recent reports detailing significant changes in the development of a neoplastic phenotypic associated with features of the 5' untranslated leader sequence of oncogene mRNAs; moreover, interactions of protein(s) with the 5' leader of the human immunodeficiency virus mRNAs influence expression of viral gene products.
对疾病分子机制的完整理解 需要阐明定义细胞的控制机制 结构和功能。 本项目的目标是定义 选择性信使RNA翻译的分子基础, 表征mRNA序列和/或结构的特征, 形成特异性信使RNA蛋白复合物的信号。 应激或病毒感染的细胞选择性地翻译一个亚群, 总mRNA库和5'非翻译前导序列中的核苷酸 信使RNA的序列促进差异表达。 一种植物病毒信使RNA,苜蓿花叶病毒RNA 4, 因为它被有效地表达, 选择性地在从感染了 脊髓灰质炎病毒,其中其他信使RNA的易位是 废除 序列和/或结构的鉴定 苜蓿花叶病毒RNA 4(AMV RNA 4)的特征, 病变细胞中的翻译活性将增加 了解信使RNA通常是如何被选择用于 翻译,并可能建议协议,以打击病毒 感染或用于防止细胞在应激期间关闭 条件 初步研究表明, 选择性翻译 核苷酸缺失的组合 实验和肽互补分析将用于 描述选择性AMV RNA 4的分子基础 翻译. 尽管暗示特定的信使RNA- 蛋白质的相互作用形成了重要的调控基础, 机制,很少有特定的mRNA-蛋白质复合物的例子 已经被详细描述和研究。 初步研究 证明两种不相关的蛋白质特异性结合3 '- AMV RNA末端片段4. 特异性结合分析 AMV外壳蛋白(CP)和哺乳动物双链 RNA依赖性蛋白激酶(dsI)的180个核苷酸的片段, RNA 4提供了一个不寻常的机会来检查mRNA蛋白质 交互. AMV RNA 4-CP复合物的表征将 有助于理解病毒交叉的分子基础, 保护植物;此外,初步研究表明, 植物病毒RNA片段是哺乳动物dsI的有效激活剂 激酶。 迁移率谱带位移电泳与硝酸纤维素 过滤器保留研究将用于表征特定的 苜蓿花叶病毒RNA 4与CP/dsI相互作用 核苷酸缺失分析和定点突变将在 用于探测RNA和蛋白质结合位点。 的 大量CP的可用性允许扩展 分析包括物理研究。 直接临床相关性 在最近的报告中可以发现, 与以下特征相关的肿瘤表型的发展 癌基因mRNA的5'非翻译前导序列;此外, 蛋白质与人的5'前导序列的相互作用 免疫缺陷病毒mRNAs影响病毒基因表达 产品.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lee Gehrke其他文献

Lee Gehrke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lee Gehrke', 18)}}的其他基金

Administrative Core: 3D Models of Engineered Human iPS Cells to Investigate Neurotropic Virus Infections
管理核心:用于研究嗜神经病毒感染的工程化人类 iPS 细胞 3D 模型
  • 批准号:
    9312526
  • 财政年份:
    2017
  • 资助金额:
    $ 28.81万
  • 项目类别:
3D Models of Engineered Human iPS Cells to Investigate Neurotropic Virus Infections
用于研究嗜神经病毒感染的工程化人类 iPS 细胞 3D 模型
  • 批准号:
    9903201
  • 财政年份:
    2017
  • 资助金额:
    $ 28.81万
  • 项目类别:
Human Cells and Tissues Core: 3D Models of Engineered Human iPS Cells to Investigate Neurotropic Virus Infections
人类细胞和组织核心:用于研究嗜神经病毒感染的工程化人类 iPS 细胞 3D 模型
  • 批准号:
    9312528
  • 财政年份:
    2017
  • 资助金额:
    $ 28.81万
  • 项目类别:
Project 2: Use of 2D cultures and 3D organoids to identify candidate antiviral compounds; to use genetic approaches to identify host genes that promote or protect against flavivirus infection
项目 2:使用 2D 培养物和 3D 类器官来鉴定候选抗病毒化合物;
  • 批准号:
    9312530
  • 财政年份:
    2017
  • 资助金额:
    $ 28.81万
  • 项目类别:
MMDx: A rapid multiplexed matrix code diagnostic for real time epidemiology
MMDx:用于实时流行病学的快速多路复用矩阵代码诊断
  • 批准号:
    8915035
  • 财政年份:
    2012
  • 资助金额:
    $ 28.81万
  • 项目类别:
Synergistic innate immune activation and cell killing by RIG-I ligands in HCV-HCC
HCV-HCC 中 RIG-I 配体的协同先天免疫激活和细胞杀伤
  • 批准号:
    8441526
  • 财政年份:
    2012
  • 资助金额:
    $ 28.81万
  • 项目类别:
Synergistic innate immune activation and cell killing by RIG-I ligands in HCV-HCC
HCV-HCC 中 RIG-I 配体的协同先天免疫激活和细胞杀伤
  • 批准号:
    8238622
  • 财政年份:
    2012
  • 资助金额:
    $ 28.81万
  • 项目类别:
MMDx: A rapid multiplexed matrix code diagnostic for real time epidemiology
MMDx:用于实时流行病学的快速多路复用矩阵代码诊断
  • 批准号:
    8467676
  • 财政年份:
    2012
  • 资助金额:
    $ 28.81万
  • 项目类别:
MMDx: A rapid multiplexed matrix code diagnostic for real time epidemiology
MMDx:用于实时流行病学的快速多路复用矩阵代码诊断
  • 批准号:
    8901539
  • 财政年份:
    2012
  • 资助金额:
    $ 28.81万
  • 项目类别:
MMDx: A rapid multiplexed matrix code diagnostic for real time epidemiology
MMDx:用于实时流行病学的快速多路复用矩阵代码诊断
  • 批准号:
    8301236
  • 财政年份:
    2012
  • 资助金额:
    $ 28.81万
  • 项目类别:

相似海外基金

Role of novel RNA binding protein LARP6 in alcoholic cardiomyopathy
新型RNA结合蛋白LARP6在酒精性心肌病中的作用
  • 批准号:
    10593688
  • 财政年份:
    2023
  • 资助金额:
    $ 28.81万
  • 项目类别:
Targeting of RNA-binding protein FXR1 in HNSCC
HNSCC 中 RNA 结合蛋白 FXR1 的靶向
  • 批准号:
    10571379
  • 财政年份:
    2023
  • 资助金额:
    $ 28.81万
  • 项目类别:
Mechanisms driving Autosomal Dominant Polycystic Kidney Disease: The novel role of the RNA-binding protein ANKHD1.
常染色体显性多囊肾病的驱动机制:RNA 结合蛋白 ANKHD1 的新作用。
  • 批准号:
    MR/T04201X/2
  • 财政年份:
    2023
  • 资助金额:
    $ 28.81万
  • 项目类别:
    Fellowship
Identify the role of RNA-binding protein in activating anti-tumor immunity by directly decaying PD-L1-3'UTR
通过直接降解 PD-L1-3UTR 鉴定 RNA 结合蛋白在激活抗肿瘤免疫中的作用
  • 批准号:
    23KJ1296
  • 财政年份:
    2023
  • 资助金额:
    $ 28.81万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Anti-inflammatory Signaling of RNA-binding Protein, Tristetraprolin, During Myocardial Infarction
RNA 结合蛋白 Tristetraprolin 在心肌梗死期间的抗炎信号传导
  • 批准号:
    10644962
  • 财政年份:
    2023
  • 资助金额:
    $ 28.81万
  • 项目类别:
Formation and function of pathologic stress granules containing RNA-Binding Protein SFPQ in tauopathy
tau蛋白病中含有RNA结合蛋白SFPQ的病理应激颗粒的形成和功能
  • 批准号:
    10581946
  • 财政年份:
    2023
  • 资助金额:
    $ 28.81万
  • 项目类别:
ERK-mediated regulation of RNA binding protein condensation during female germ cell development
ERK 介导的雌性生殖细胞发育过程中 RNA 结合蛋白凝聚的调节
  • 批准号:
    10514951
  • 财政年份:
    2022
  • 资助金额:
    $ 28.81万
  • 项目类别:
Role of RNA-binding protein in immune evasion of Mtb in macrophages
RNA结合蛋白在巨噬细胞中Mtb免疫逃避中的作用
  • 批准号:
    10634764
  • 财政年份:
    2022
  • 资助金额:
    $ 28.81万
  • 项目类别:
Post-transcriptional regulation by the YBX3 RNA-binding protein in skeletal muscle
骨骼肌中 YBX3 RNA 结合蛋白的转录后调节
  • 批准号:
    10439013
  • 财政年份:
    2022
  • 资助金额:
    $ 28.81万
  • 项目类别:
Evolution of RNA Binding Protein Regulation of Brain Development
RNA结合蛋白对大脑发育调节的进化
  • 批准号:
    2735241
  • 财政年份:
    2022
  • 资助金额:
    $ 28.81万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了